T. Rowe Price Associates’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $244K | Buy |
|
|||||
|
2025
Q2 | $202K | Buy |
|
|||||
|
2025
Q1 | $195K | Buy |
|
|||||
|
2024
Q4 | $118K | Buy |
|
|||||
|
2024
Q3 | $152K | Sell |
|
|||||
|
2024
Q2 | $299K | Buy |
|
|||||
|
2024
Q1 | $263K | Buy |
|
|||||
|
2023
Q4 | $260K | Buy |
|
|||||
|
2023
Q3 | $183K | Sell |
|
|||||
|
2023
Q2 | $293K | Sell |
|
|||||
|
2023
Q1 | $291K | Buy |
|
|||||
|
2022
Q4 | $249K | Buy |
|
|||||
|
2022
Q3 | $391K | Buy |
|
|||||
|
2022
Q2 | $207K | Buy |
|
|||||
|
2022
Q1 | $270K | Buy |
|
|||||
|
2021
Q4 | $194K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.78M | Hold |
|
|||||
|
2016
Q1 | $1.73M | Buy |
|
|||||
|
2015
Q4 | $9.72M | Sell |
|
|||||
|
2015
Q3 | $9.92M | Sell |
|
|||||
|
2015
Q2 | $20M | Buy |
|